ERBB2 and neoplasm: 89 patients were classified, and the detection rates of CTLM imaging in different breast densities, tumor sizes, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor -2 (HER2) expression were compared.